Latest News of SYRS
Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS) high institutional ownership speaks for itself as stock continues to impress, up 17% over last week
By Yahoo! Finance |
3 months ago
Understanding ownership research and analyst forecasts can provide insights into stock opportunities. For example, in Syros Pharmaceuticals, institutions hold a 32% stake, indicating potential upside ...